John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Royal Gold
RGLD
$22.3B
| $3.18M | 0.02% |
87,193
-121,797
| -58% | -$5.09M |
|
|
TYPE
852
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $3.18M | 0.02% |
134,514
-19,336
| -13% | -$475K |
|
853
NiSource
NI
$19.6B
| $3.17M | 0.02% |
+162,394
| New | +$3.12M |
|
|
CIM
854
Chimera Investment
CIM
$973M
| $3.16M | 0.02% |
+77,199
| New | +$3.24M |
|
855
Albany International
AIN
$1.66B
| $3.15M | 0.02% |
86,279
+38,293
| +80% | +$1.36M |
|
856
Agnico Eagle Mines
AEM
$110B
| $3.15M | 0.02% |
+119,948
| New | +$3.27M |
|
857
Papa John's
PZZA
$793M
| $3.14M | 0.02% |
+56,200
| New | +$3.47M |
|
858
Viavi Solutions
VIAV
$9.12B
| $3.13M | 0.02% |
513,655
+164,290
| +47% | +$996K |
|
859
Greenlight Captial
GLRE
$507M
| $3.11M | 0.01% |
166,181
+112,040
| +207% | +$2.39M |
|
|
BPT
860
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $3.1M | 0.01% |
+124,397
| New | +$4.38M |
|
861
EXL Service
EXLS
$5.71B
| $3.1M | 0.01% |
+345,045
| New | +$3.01M |
|
|
SGEN
862
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.09M | 0.01% |
+68,949
| New | +$2.87M |
|
|
RATE
863
DELISTED
Bankrate Inc
RATE
| $3.09M | 0.01% |
+232,508
| New | +$3.07M |
|
|
IMPV
864
DELISTED
Imperva, Inc.
IMPV
| $3.09M | 0.01% |
+48,776
| New | +$3.32M |
|
|
AIV
865
Aimco
AIV
$378M
| $3.08M | 0.01% |
+577,724
| New | +$2.97M |
|
866
Korn Ferry
KFY
$4.35B
| $3.07M | 0.01% |
92,621
+28,182
| +44% | +$989K |
|
|
RTEC
867
DELISTED
Rudolph Technologies Inc
RTEC
| $3.07M | 0.01% |
215,992
+147,475
| +215% | +$2.03M |
|
868
Rexford Industrial Realty
REXR
$8.4B
| $3.07M | 0.01% |
+187,513
| New | +$2.91M |
|
|
STKL
869
DELISTED
SunOpta
STKL
| $3.07M | 0.01% |
448,558
+282,124
| +170% | +$1.75M |
|
|
MNTA
870
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.07M | 0.01% |
206,631
+62,222
| +43% | +$1.04M |
|
|
SALE
871
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $3.07M | 0.01% |
309,029
+289,129
| +1,453% | +$2.79M |
|
872
Braskem
BAK
$733M
| $3.06M | 0.01% |
+226,198
| New | +$2.76M |
|
|
CCP
873
DELISTED
Care Capital Properties, Inc.
CCP
| $3.06M | 0.01% |
+100,093
| New | +$3.19M |
|
874
CALL
Morgan Stanley
MS
$336B
| $3.05M | 0.01% |
96,000
+86,000
| +860% | +$2.86M |
|
|
EOCC
875
DELISTED
Enel Generacion Chile S.A.
EOCC
| $3.05M | 0.01% |
119,091
+34,405
| +41% | +$873K |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.